Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date

Overview of attention for article published in OncoTargets and therapy, July 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 2 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,379 followers.

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date. #lymphoma #lymsm https://t.co/xVXPd7g0M8

07 Aug 2020

Reply Repost Favourite

New article: Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date. https://t.co/nzrMTWS5ea #MCL #lymsm #hematology https://t.co/dj1KmDP286

06 Aug 2020